Cargando…
Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
The immune checkpoint blockade represents a revolution in cancer therapy, with the potential to increase survival for many patients for whom current treatments are not effective. However, response rates to current immune checkpoint inhibitors vary widely between patients and different types of cance...
Autores principales: | Doty, Daniel T., Schueler, Julia, Mott, Vienna L., Bryan, Cassie M., Moore, Nathan F., Ho, John C., Borenstein, Jeffrey T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555450/ https://www.ncbi.nlm.nih.gov/pubmed/32899865 http://dx.doi.org/10.3390/ijms21186478 |
Ejemplares similares
-
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
por: Noelle, Randolph J., et al.
Publicado: (2023) -
A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies
por: Moore, Nathan, et al.
Publicado: (2019) -
Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019) -
Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)